Form4insider filings, from the source

Insider holders · CIK 0001664710

Keros Therapeutics, Inc. · KROS

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Julius KnowlesDirector10,958102,233113,191Jun 8, 2026 · 4:36 pm EDTForm 4
Annita TaniniCorp. Controller & VP, Finance45,144—45,144Aug 20, 2026 · 4:10 pm EDTForm 4
Esther ChoChief Legal Officer35,770—35,770Aug 20, 2026 · 4:10 pm EDTForm 4
Lorena Raquel LernerChief Scientific Officer27,559—27,559Aug 20, 2026 · 4:10 pm EDTForm 4
Jean Jacques BienaimeDirector19,592—19,592Aug 19, 2026 · 4:10 pm EDTForm 4
Anne PrenerDirector13,786—13,786Jul 6, 2026 · 4:31 pm EDTForm 4
Alpna SethDirector12,392—12,392Jun 5, 2026 · 5:20 pm EDTForm 4
Mary Ann GrayDirector12,392—12,392Jun 5, 2026 · 4:15 pm EDTForm 4
Charles W. NewtonDirector12,114—12,114Aug 20, 2026 · 4:10 pm EDTForm 4
Nima FarzanDirector9,767—9,767Jun 8, 2026 · 4:37 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.